NewsRx

Search our medical news database

BBN Technologies

BBN Technologies Awarded $14 Million in DoD Funding to Advance Rapid Foreign Language Processing

Published in Health Business Week, August 14th, 2009

BBN Technologies, an advanced technology solutions firm, has been awarded $14 million in funding by the Defense Advanced Research Projects Agency (DARPA) in the fourth year of the five-year Global Autonomous Language Exploitation (GALE) program. The goal of GALE is to develop and apply software technologies to transcribe, translate, and distill large volumes of speech and text in multiple languages - all with more than 90% accuracy by the end of the program. Such a capability would help U.S. analysts recognize critical information in foreign languages quickly.

During the first three years of the GALE program, BBN met or exceeded the accuracy goals for automatic...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook